Gilead Sciences (NASDAQ:GILD)

Short Interest Pulls Back in Major Biotechs

The short interest data are out for the most recent settlement date, March 15. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

How Health Care Stocks Responded to the Shelved Health Care Bill

Despite touting himself as an incredible dealmaker and negotiater, Trump faced the biggest defeat of his presidency thus far when legislation to repeal the Affordable Care Act was pulled from ...
Read Full Story »

Jefferies Has 4 Red-Hot Biotech and Pharmaceutical Stocks to Buy Now

If any sector is offering value in what really appears to be a very overbought stock market, it is pharmaceutical, including biotechnology. Absolutely battered during the election cycle when rhetoric over ...
Read Full Story »

What a Combined Gilead and Incyte Would Look Like

Gilead Sciences Inc. (NASDAQ: GILD) has long been in need of a catalyst to move its business, and a lot of investors and analysts alike have considered this company dead ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AIG, Boeing, GameStop, Gilead, Starbucks, CIGNA, Ciena, Ferrari and Many More

Stocks were indicated to open marginally higher on Monday, but all eyes remain on the Federal Open Market Committee (FOMC) ahead of this week's interest rate hike decision. The odds ...
Read Full Story »

Major Biotechs See a Retreat in Short Interest

The short interest data are out for the most recent settlement date, February 28. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Top Analyst Upgrades and Downgrades: American Express, Amgen, Encana, Gilead, Tesla and Many More

Stocks were indicated lower on Thursday ahead of Friday's key payrolls and unemployment report. The European Central Bank maintained rates at 0.00%. Now that the bull market is officially eight years ...
Read Full Story »
biotech word cloud

Short Sellers Hike Their Bets in Major Biotechs

The short interest data are out for the most recent settlement date, February 15. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »
Chevron logo

Jefferies Says Buy These Dividend-Paying Companies That Missed Expectations

We have written on numerous occasions that it has become harder with each passing trading day to find stocks that are not sky-high expensive. We are in the phase of ...
Read Full Story »
Medical vaccine in shoulder, vaccination

What Analysts Are Prescribing Gilead After Earnings

Gilead Sciences Inc. (NASDAQ: GILD) reported fourth-quarter earnings after markets closed on Tuesday. The stock hit a new multiyear low on Wednesday and pushed even lower on Thursday to a price ...
Read Full Story »
Wow

Major Biotechs Scare Off Loads of Short Sellers

The short interest data are out for the most recent settlement date, January 31. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »
Stock Price

Vista Outdoor, Fossil Group Dive into Thursday’s 52-Week Low Club

February 9, 2017: Here are four stocks trading with relatively heavy volume among 35 equities making new 52-week lows in Thursday's session. On the NYSE, advancers led decliners nearly 2 ...
Read Full Story »
Stock Price

Gilead Sciences, Fitbit Plunge into Wednesday’s 52-Week Low Club

February 8, 2017: Here are four stocks trading with relatively heavy volume among 69 equities making new 52-week lows in Wednesday's session. On the NYSE, advancers led decliners by less than ...
Read Full Story »
thumbs up and down

What Analysts Are Saying About Gilead Sciences After Earnings

After Gilead Sciences Inc. (NASDAQ: GILD) reported fourth-quarter earnings after markets closed on Tuesday, the stock hit a new multiyear low, not seen since 2014. Across the board analysts saw ...
Read Full Story »
Prescription Drugs, Pills

Wednesday’s Biggest Biopharma Movers

Not that many biotech and pharma companies were on the move Wednesday, but a few of the smaller caps made splash, while one giant company posted a massive loss. Although ...
Read Full Story »